Dr. Sanjay Gupta interviews Kannalife Sciences CEO Dean Petkanas and the exclusive license to the US Government’s patent on Cannabis. “Cannabinoids as Antioxidants and Neuroprotectants”.
Kannalife is working on two (2) distinct disease indications that effect the Brain. One is a brain-liver disease called Hepatic Encephalopathy (HE) and the second is a concussion related traumatic brain injury called Chronic Traumatic Encephalopathy (CTE).